Participants will learn how to incorporate anti-obesity medications (AOMs) into treatment plans, how to assess and document a patients medication and supplement history, and how to tailor interventions for specific populations affected by obesity
Before and after the intervention, VO 2 max, body composition, total hemoglobin (Hb) mass and blood volumes were assessed
Our providers start conservatively and titrate based on responsethere's no benefit to "megadosing" and it increases both cost and potential side effects
[5] Observational studies provide additional context but face methodological challenges: patients prescribed GLP-1 receptor agonists typically have more advanced metabolic disease, higher body mass index, and greater baseline pancreatitis risk than comparison groups
Because of its effect on your blood sugar levels, GLP-1 medications are prescribed to help control type 2 diabetes
We included original studies, reviews, view points, commentaries, case series and case reports which were relevant to our objectives
